Trial Profile

Study of Peripheral Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 09 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Infliximab (Primary)
Indications Ankylosing spondylitis
Focus Therapeutic Use
Acronyms EUSpA
Sponsors Merck Sharp & Dohme; Schering-Plough

Most Recent Events

15 Jun 2019 This trial has been discontinued in France, according to European Clinical Trials Database.
02 Nov 2012 Planned number of patients changed from 100 to 120 as reported by European Clinical Trials Database.
10 Mar 2010 Actual patient number (7) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com